X0609 4 2026-03-26 0 0002022416 Silexion Therapeutics Corp SLXN 0001727789 Shirvan Mitchell true C/O SILEXION THERAPEUTICS CORP 12 ABBA HILLEL ROAD RAMAT GAN L3 5250606 ISRAEL 0 1 0 0 CSO and CDO 0 Ordinary Shares 2026-03-26 4 S 0 22818 1.36 D 27889 D Stock Option (right to buy Ordinary Shares) 907.71 2024-08-15 2032-06-07 Ordinary Shares 478 478 D The transaction was a sale-to-cover to cover tax liability stemming from the Reporting Person's receipt of a grant of fully vested restricted share units on February 20, 2026, as reported in the Form 4 filed by the Reporting Person on February 23, 2026. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. The number of options to purchase ordinary shares, underlying ordinary shares, and the exercise price of those options reported in this row have been adjusted to reflect a 1-for-9 reverse share split effected by the Issuer on November 29, 2024 and a 1-for-15 reverse share split effected by the Issuer on July 29, 2025. /s/ Mirit Horenshtein Hadar, Attorney-in-fact 2026-03-30